Deerfield Management Company, L.P. (Series C) Tyra Biosciences, Inc. Put Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TYRA
# of Institutions
123Shares Held
59.8MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$191 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$63.9 Million93.82% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$63.5 Million7.35% of portfolio
-
Nextech Invest Ag4.06MShares$63.5 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$61.7 Million1.48% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $657M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...